Posts Tagged ‘botulinum-toxin’

Allergan Announces FDA Approval of Label Extensions for JUVEDERM(TM) Ultra and JUVEDERM(TM) Ultra Plus

26, Jun 2007

Only Hyaluronic Acid Dermal Fillers Approved to Last up to 1 Year IRVINE, Calif.–(HSMN NewsFeed)–Allergan, Inc. (NYSE:AGN ), the maker of BOTOX? Cosmetic (Botulinum Toxin Type A), today announced approval by the U.S.

New Data Featuring Products from Allergan’s Total Facial Rejuvenation(TM) Offering Presented at the American Academy of Dermatology (AAD) Winter…

9, Feb 2007

Allergan-supported scientific posters on BOTOX(R) Cosmetic (botulinum toxin type A), BOTOX(R) (botulinum toxin type A) for hyperhidrosis and JUVEDERM(TM) ULTRA and JUVEDERM(TM) ULTRA PLUS, the “next-generation” hyaluronic acid dermal fillers, will be presented at this year’s winter meeting of the American Academy of Dermatology (AAD). …


Copryright 2012 - Epione Medical Corporation | About us | Treatments | Contact us | Online Store

Share to Facebook Share to Twitter Stumble It Email This More...